FDA warns public against fake COVID-19 vaccines sold online

Robie de Guzman   •   September 30, 2021   •   369


MANILA, Philippines – The Philippine Food and Drug Administration (FDA) on Thursday warned the public against buying COVID-19 vaccine brands allegedly being sold on social media and other online selling platforms.

In an advisory, the FDA said that COVID-19 vaccine brands such as AstraZeneca, Pfizer, and Moderna are allegedly being offered online.

But the agency said the scheme is just a “scam” to attract those who prefer the said brands.

“The public is advised that this is a scam which uses online platforms and social media to attract buyers specially those who have preference on the brand of vaccines specifically our countrymen who work abroad (OFWs),” it said.

The FDA said that scammers involved in this scheme are offering the supposed vaccine brands in a promo deal like buy 2 take 1 deal.

“Once you place your order to the online selling platform, the seller will send a chat message and will give his private contact numbers usually Viber, WeChat, or WhatsApp,” the agency said.

“Payment will be requested to be settled thru Gcash or bank transfer prior to the arrangement of delivery. After the payment, another person/number will send a message asking for courier or delivery fee. When the delivery fee has been paid, another person will send a message asking for the payment of insurance fee. No vaccine product will be delivered even when all payments have been settled,” it added.

The FDA reminded that public that COVID-19 vaccines currently available can only be used under emergency authorization and are not for sale. These are also strictly administered and distributed by national healthcare regulators.

The agency reiterated its call to remain vigilant against counterfeit drugs.

Pagbabakuna sa mga edad 11 pababa posibleng simulan bago matapos ang 2021 – FDA

Robie de Guzman   •   November 23, 2021

MANILA, Philippines – Naniniwala ang Food and Drug Administration (FDA) na malaki ang tiyansang masimulan na rin ngayong taon ang pagbabakuna laban sa COVID-19 para sa mga batang may edad 11 at pababa.

Ayon kay FDA director general Eric Domingo, dalawang vaccine manufacturers na ang nag-aasikaso sa ngayon ng requirements para maaprubahan ang aplikasyon para sa emergency use authorization (EUA) ng kanilang mga bakuna para sa nakababatang populasyon.

“I would think before end of the year. I am pretty sure Pfizer is going to be ready. The Sinovac also told us that their data is being collated and it will be submitted soon,” ani Domingo.

“I believe before the end of the year, we are going to have vaccines for children below 12,” dagdag pa niya.

Sakaling makumpleto ng vaccine manufacturers ang requirements para ma-amyendahan ang dosing regimen ng kanilang mga bakuna ay maaaring mabigyan na ng bakuna ang mga batang may edad lima hanggang 11 bago pa pumasok ang 2022.

“By Pfizer, I hope that they will be sending in their application for an EUA very soon. Nagtanong na sila eh, they have already asked for the list of requirements and they told us that they will be completing the requirements,” ani Domingo.

“It is like a new EUA kasi may bagong innovation doon sa product,” dagdag pa niya.

“Ang Sinovac rin hinihintay pa ulit namin na mag-submit ng EUA nila for children below 18 years old. They just want to complete some more data to give to our vaccine experts and we hope to get that soon,” ang wika ni Domingo.

Ang pagbabakuna sa 5-11 age group ay sinimulan na sa mga bansang Amerika at Israel upang upang mabigyan ng proteksyon kontra COVID-19 ang mga bata dahil sa banta ng mababagsik na coronavirus variants gaya ng Delta.

Lumabas din sa mga pag- aaral ng mga eksperto na sampung beses na mas may tiyansang mahawa sa COVID-19 ang mga batang 12 taong gulang at pababa.

Sa ngayon, ang mga batang may edad 12 hanggang 17 pa lamang ang binabakunahan kontra COVID-19 sa Pilipinas. (mula sa ulat ni Correspondent Aiko Miguel)

COVID-19 pill molnupiravir, maaaring ireseta basta’t may compassionate special permit – FDA

Robie de Guzman   •   November 23, 2021

MANILA, Philippines – Maaari nang mag-reseta ng COVID-19 pill na molnupiravir ang mga ospital at doktor na nabigyan ng compassionate special permit.

Ginawa ni Food and Drug Administration (FDA) director general Eric Domingo ang pahayag matapos sabihin ni Vice President Leni Robredo na may supply na sila ng molnupiravir na maaaring ireseta sa mga kokonsulta sa Bayanihan E-Konsulta program ng kanyang tanggapan.

Ang gamot na molnupiravir ay isang oral pill para sa treatment ng mild to moderate cases ng COVID-19.

Ani Domingo, ang mga doktor at ospital na nabigyan ng compassionate special permit ang may obligasyong mag-monitor sa mga pasyenteng bibigyan ng oral antiviral pill.

Sa isang Facebook post noong Lunes, sinabi ni Robredo na may kasunduan na ang Office of the Vice President (OVP) sa Qualimed Health Network na siyang magus-supply at magre-reseta ng molnupiravir sa mga pasyenteng dudulog sa kanilang teleconsultation program.

“In the agreement, the OVP will issue a guarantee letter under our special medical assistance program to any qualified patient referred by our volunteer doctors at Bayanihan E-Konsulta. QualiMed facilties will then further assess and prescribe the medicine to the patient,” ani Robredo.

Inihayag rin ni Robredo na ang unang shipment ng nasabing gamot ay dumating sa bansa noong Nobyembre 17.

Sa isang Twitter post naman ni Manila Mayor Francisco “Isko Moreno” Domagoso, sinabi niyang may 40,000 capsules ng molnupirarvir ang nasa anim na district hospitals at COVID-19 field hospitals ng Maynila.

Sa datos ng mga ekspertong nagsagawa ng clinical trials sa iba’t ibang bansa, kabilang ang dalawang ospital sa Pilipinas, sinasabing mabisa ang molnunpiravir para maiwasang maopsital at masawi ang isang pasyenteng may COVID-19.

Kumpara sa ibang COVID-19 investigational drugs, ang molnupiravir ay idinesenyo para sa early treatment ng mga pasyente.

Ngunit paalala ng FDA, hindi pa maaaring ibenta sa merkado ang naturang gamot dahil wala pa itong certificate of product registration.

Una nang sinabi ng ahensiya na hindi maaaring ipagbili ang mga gamot o bakuna na wala pang emergency use authorization at hindi pa rehistrado sa bansa. (Mula sa ulat ni Correspondent Aiko Miguel)

Over 682K Moderna vaccine doses arrive in Philippines

Robie de Guzman   •   November 23, 2021

MANILA, Philippines – Another batch of Moderna COVID-19 vaccine doses arrived in the country Tuesday morning, the National Task Force (NTF) against COVID-19 said.

The NTF said the shipment contains a total of 682,360 vaccine doses procured by the Philippine government.

Since February, the country has received over 130 million doses of various COVID-19 vaccine brands.

The latest shipment is expected to be used in the inoculation of booster doses for senior citizens and selected immunocompromised individuals.

As of November 22, a total of 33,847,741 individuals have been fully vaccinated against coronavirus disease, according to government data.


The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)


UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.